Fine structure in proton emission from 145Tm discovered with digital signal processing.

Fine structure in proton emission from the 3.1(3) mus activity of 145Tm was discovered by using a novel technique of digital processing of overlapping recoil implantation and decay signals. Proton transitions to the ground state of 144Er and to its first excited 2(+) state at 0.33(1) MeV with a branching ratio I(p)(2(+))=9.6+/-1.5% were observed. The structure of the 145Tm wave function and the emission process were analyzed by using particle-core vibration coupling models.

Effects of therapeutic doses of albuterol on beta2-adrenergic receptor density and metabolic changes.

Beta2-agonist drugs at inhaled supratherapeutic doses or when given orally or parenterally alter peripheral lymphocyte beta2-adrenoceptor density (betaAR) and have demonstrable metabolic effects. However, it is not known whether these changes occur at therapeutic inhaled doses. We therefore studied the effects of therapeutic doses of inhaled albuterol in five asthmatic subjects (mean age 23.0+/-2.4 years) and six normal subjects (mean age 28.3+/-3.3 years). Subjects were studied in a randomized, double-blind protocol in which each subject received either inhaled albuterol (270 microg four times daily) for 2 weeks followed by placebo or vice versa in two sequential 2-week periods separated by a 2-week washout period. In the asthmatics, baseline FEV1 increased significantly (p < 0.05) after 2 weeks of inhaled albuterol treatment compared to the initial visit and after 2 weeks of placebo (mean FEV1: 3.2 L+/-0.7 L, 2.9 L+/-0.5 L, and 3.0 L+/-0. 7 L, respectively). Baseline peripheral lymphocyte betaAR was not significantly different (p > 0.05) between the asthmatic (mean: 757+/-176) and normal subjects (mean: 732+/-251). However, in neither group was there any significant change (p > 0.05) in betaAR or plasma potassium, insulin, or glucose, either acutely or after 2 weeks of albuterol therapy. The present study confirms that there is no difference in peripheral lymphocyte betaAR between asthmatic and normal subjects and also shows that at therapeutic doses of inhaled albuterol, there are no significant changes in betaAR or metabolic effects.

Effects of acute prolonged exposure to high-altitude hypoxia on exercise-induced breathlessness.

The direct effects of hypoxia on exercise-induced breathlessness are unclear. Increased breathlessness on exercise is known to occur at high altitude, but it is not known whether this is related to the hypoxia per se, or to other ventilatory parameters. To examine the role of high-altitude hypoxia in exercise-induced breathlessness, studies were performed in 10 healthy, normal subjects at sea level and after acute exposure to an altitude of 4450 m. Although the perception of hand weights did not alter between sea level and high altitude, the intensity of exercise-induced breathlessness increased significantly at high altitude. This was associated with a higher minute ventilation and respiratory frequency for any given exercise level, whereas tidal volume was not significantly altered from sea level values. The increased intensity of breathlessness with exercise did not change significantly over the 5 days at high altitude. These results suggest that the increased intensity of exercise-induced breathlessness at high altitude is not related to peripheral mechanisms or the pattern of ventilation, or to the level of hypoxia per se, but to the level of reflexly increased ventilation.

Are patients fed appropriately according to their caloric requirements?

BACKGROUND: Specific morbidity related to underfeeding and overfeeding necessitates the design of nutrition support regimens that provide calories equal to those required on the basis of energy expenditure. This prospective multicenter trial was designed to determine what percent of patients in long-term acute care facilities receive feeding appropriate to their needs and whether accuracy of feeding has an impact on patient clinical status. METHODS: Patients on mechanical ventilation who were hospitalized at 32 Vencor Hospitals over a 9-week period and who were receiving only enteral nutrition by continuous infusion at a presumed goal rate were evaluated once by indirect calorimetry (IC) while on feeding. Caloric intake over the preceding 24 hours was determined by physician orders and by patient intake/output (I/O) record. Caloric requirements were defined by measured resting energy expenditure (REE) + 10% for activity. Degree of metabolism was defined by the ratio: (measured REE/Harris-Benedict predicted REE) x 100, and the degree of feeding by the ratio: (calories provided/calories required) x 100. RESULTS: IC was performed on 335 patients (mean, 11.2 patients per center; range, 1 to 32), of which 72 were excluded for nonphysiological results or failure to achieve steady state, 21 for receiving parenteral nutrition, and 29 for not being on mechanical ventilation at time of testing. The 213 study patients were 58.7% male with mean age 70.1 years (range, 20 to 90 years). Measured REE was <25 kcal/kg in 66.2% of patients and 25 to 35 kcal/kg in 28.6%. Barely half (48.4%) of this patient population was hypermetabolic. Based on physician orders, the majority of patients (58.2%) were overfed, receiving >110% of required calories, and 12.2% were underfed, receiving <90% of requirements. Discrepancies based on I/O records, however, suggested that 36.1% of patients received <90% of those calories ordered. By either basis, only about 25% of patients received feeding within 10% of required calories. The percent of patients being overfed varied between centers, ranging from 32.2% to 92.8%, and was not affected by years of facility IC experience or volume of IC studies per month. The pattern of caloric provision as measured by degree of feeding correlated inversely to degree of metabolism (p < .0001, R2 = .24). Accuracy of feeding had an impact on ventilatory status, as degree of feeding correlated inversely with minute ventilation (p = .001, R2 = .05). Degree of overfeeding also led to significant increases in azotemia (p = .033, R2 = .02). Extrapolating study data over 1 year, reduction in excess volume of enteral formula would have resulted in a cost savings of up to $1.3 million for the Vencor system. CONCLUSIONS: Because energy expenditure is difficult to predict on the basis of conventional equations, patients in long-term acute care facilities routinely are overfed and underfed, with only 25% receiving calories within 10% of required needs. Measuring a patient's energy requirement at least once by IC is important, because the degree of metabolism predicts how easily a patient will be underfed or overfed. The amount of infused calories should be compared with caloric requirements measured by IC, because the accuracy or degree of underfeeding or overfeeding has an impact on ventilatory status and the likelihood for developing azotemia. Although physician practice or bias may reduce the optimal clinical effect, the use of IC to determine caloric requirements may result in significant cost savings.

Isocapnic hypoxemia and neuropsychological functioning.

We evaluated the cognitive effects of hypoxemia independent of hypocapnia in 20 right-handed male subjects using a battery of brief neuropsychological tests. Results of a profile analysis indicated that performance during hypoxia was reliably different for Digit Symbol and Finger Tapping tests. Trend analysis demonstrated a significant linear pattern for Finger Tapping results, such that lower levels of oxygen were associated with slower rates of tapping. No significant trends were observed for Digit Symbol results. The observation of hypoxic effects on Digit Symbol and Finger Tapping tests is consistent with previous findings of neuropsychological changes secondary to hypoxia. The negative results observed for the remaining tests are inconsistent with past literature. It is likely that methodological differences contributed to these discrepancies, including previous reliance on inspired air to index hypoxemia rather than monitoring arterial oxygen saturation directly and failure to control for differences in CO2 levels during induced hypoxia. These variables should be controlled in future research.

Safety and efficacy of using high-dose topical and nebulized anesthesia to obtain endobronchial cultures.

We evaluated the safety and efficacy of high-dose topical and nebulized airway anesthesia in normal volunteers and in patients undergoing diagnostic fiberoptic bronchoscopy. Lidocaine solution (4 percent) was used for gargling, for spraying the palate and oropharynx with an atomizer, and for nebulization with an air-powered nebulizer (mean total dose, 1,682 mg) and 2 percent lidocaine (Xylocaine) jelly for anesthetizing nasal passages. In six normal subjects and in eight patients, lidocaine blood levels were measured at baseline, after gargling, after spraying, after nebulization, and then at 5, 10, 15, 30, and 60 min; 19 normal subjects and ten patients underwent the same anesthesia protocol but had no blood drawn. Fiberoptic bronchoscopy was performed in 21 normal volunteers and in 18 patients and cultures obtained using the protected specimen brush. Additional endobronchial lidocaine (mean 256 mg) was given to the 18 patients after collecting the microbiology specimens. Peak lidocaine blood levels remained below 6 micrograms/ml in all cases. Cough and discomfort during bronchoscopic examination was absent or minimal in 17 of 21 normal subjects (80 percent) and in 14 of 18 patients (77 percent) and was severe in only one instance (5 percent). There were no related complications. Using only topical and nebulized anesthesia is safe and effective for performing fiberoptic bronchoscopy, especially when bacterial cultures are to be obtained and endobronchial instillation of lidocaine must be avoided.

The effects of hypoxemia on cardiac output. A dose-response curve.

To establish a dose-response curve for the effects of isocapnic hypoxemia on cardiac output (CO), we studied 20 healthy men, aged 20 to 34 years, using a tight-fitting face mask and an isocapnic partial rebreathing system (a modified anesthesia machine). We blended oxygen and hypoxic gas to achieve arterial oxygen saturations (SaO2) of 80, 85, and 90 percent; subjects also breathed 100 percent oxygen and room air (RA). Target SaO2 and end-tidal carbon dioxide were continuously monitored using an ear oximeter and CO2 gas analyzer. Subjects experienced the five SaO2 measurements in random order. CO was measured noninvasively at approximately two-minute intervals, using continuous-wave Doppler echocardiography. Mean cardiac output increased with increasing hypoxemia from 6.84 L/min at FIo2 1.0 to 8.44 L/min at SaO2 80 percent (p less than 0.0005); the increase was entirely due to increased heart rate. We concluded that cardiac output increases significantly in a dose-response manner in response to acute isocapnic hypoxemia in normal persons.

Biodegradation testing of radioactive waste forms.

Biodegradation tests were conducted on solidified waste forms containing ion exchange resins contaminated with high levels of radioactive nuclides. These tests were part of a program to test waste forms in accordance with the U.S. NRC Branch Technical Position on Waste Forms. Small waste forms were manufactured using two different solidification agents, Portland Type I-II cement and vinyl ester-styrene (VES). Ion exchange material was taken from a filter system which had been used to remove radionuclides from highly contaminated water. As specified by NRC, the waste forms were evaluated for their resistance to biological degradation using the G21 and G22 procedures of the American Society for Testing Materials (ASTM). Results showed that microbial growth can be supported by the VES waste forms. The particular organisms used in the tests did not grow in the presence of the cement waste forms. It is also shown that the ASTM tests specified in the Technical Position are not suitable for the use intended. A different testing methodology is recommended which would provide direct verification of waste form integrity.

Isolation of Yersinia enterocolitica from selected animal species.

Yersinia enterocolitica was isolated from 5 of 1,002 fecal samples taken from laboratory rats and mice, hamsters, dogs, cats, pigs, cattle, horses, and deer. Two isolates were from dogs (2 of 202; 1%) and 1 from a pig (1 of 107; 0.9%). The 3 isolates were biotype 1. Atypical environmental Y enterocolitica was isolated from a cow (1 of 141; 0.7%) and a horse (1 of 101; 1%). Isolates were not recovered from the other animal species.